Literature DB >> 12683405

Effect of multiple herpesvirus infections on the progression of HIV disease in a cohort of HIV seroconverters.

Barbara Suligoi1, Maria Dorrucci, Ilaria Uccella, Massimo Andreoni, Giovanni Rezza.   

Abstract

The effects of herpesviruses infection on the progression of HIV disease remain controversial, with some studies showing accelerated progression and others showing no effect. Furthermore, the effect of concurrent infection with more than one herpesvirus on the progression of HIV disease has never been investigated. To this end, the rates of progression of HIV disease were determined after stratifying for the presence of up to five different herpesvirus infections. The study population consisted of 359 HIV-infected persons for whom the date of seroconversion was estimated (part of the Italian Seroconversion Study). One serum sample from each participant was tested for antibodies to five herpesviruses: HSV-2, CMV, HHV-6, HHV-7, and HHV-8. Univariate analysis showed that HSV-2 and HHV-8 were significantly associated with progression to AIDS, yet when adjusting for age at HIV seroconversion and for the presence of the other herpesvirus infections, only HHV-8 infection showed a significant association. The age-adjusted risk of progression to AIDS with Kaposi's sarcoma increased with the number of herpesvirus infections and was significant in individuals with four infections. The risk of progression to AIDS without Kaposi's sarcoma also increased with the number of infections, although not significantly. Similar results were found when considering CD4+ cell count <200 x 10(6) cells/L as the endpoint. Concurrent infection with more than one herpesvirus does not appear to have a significant effect on the course of HIV disease, except for the known association between HHV-8 and Kaposi's sarcoma. However, even after excluding Kaposi's sarcoma from the AIDS-defining endpoints, a slightly increased risk for participants with four herpesvirus infections remained.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12683405     DOI: 10.1002/jmv.10281

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  4 in total

1.  Kaposi's sarcoma-associated herpesvirus ORF45 mediates transcriptional activation of the HIV-1 long terminal repeat via RSK2.

Authors:  John Karijolich; Yang Zhao; Bret Peterson; Qiang Zhou; Britt Glaunsinger
Journal:  J Virol       Date:  2014-04-09       Impact factor: 5.103

2.  A replication-competent, neuronal spread-defective, live attenuated herpes simplex virus type 1 vaccine.

Authors:  Elizabeth E Brittle; Fushan Wang; John M Lubinski; Ralph M Bunte; Harvey M Friedman
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

3.  HHV-8 seroprevalence in HIV-positive and HIV-negative populations.

Authors:  Julia Bohlius; Mhairi Maskew; Mary-Ann Davies; Matthias Egger
Journal:  Int J Cancer       Date:  2014-09-18       Impact factor: 7.396

Review 4.  Human Herpesviruses as Copathogens of HIV Infection, Their Role in HIV Transmission, and Disease Progression.

Authors:  Arshi Munawwar; Sarman Singh
Journal:  J Lab Physicians       Date:  2016 Jan-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.